Concord Biotech Limited (CONCORDBIO.BO)
INR 2153.4
(-1.05%)
INR 2153.4
(-1.05%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 18.87 Million INR | -70.52% |
| 2022 | 64 Million INR | -79.72% |
| 2021 | 315.59 Million INR | -45.48% |
| 2020 | 578.83 Million INR | 50.49% |
| 2019 | 384.63 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 18.87 Million INR | 0.0% |
| 2023 Q2 | 26.71 Million INR | 0.0% |
| 2023 FY | 18.87 Million INR | -70.52% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | 0.0% |
| 2022 FY | 64 Million INR | -79.72% |
| 2022 Q4 | 64 Million INR | 0.0% |
| 2021 FY | 315.59 Million INR | -45.48% |
| 2020 FY | 578.83 Million INR | 50.49% |
| 2019 FY | 384.63 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 98.609% |
| Biocon Limited | 129.32 Billion INR | 99.985% |
| Blue Jet Healthcare Limited | 3.79 Million INR | -397.889% |
| Dishman Carbogen Amcis Limited | 2.45 Billion INR | 99.232% |
| FERMENTA BIOTECH LIMITED | 425.36 Million INR | 95.564% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
| Lyka Labs Limited | 429.06 Million INR | 95.602% |
| Panacea Biotec Limited | 209.9 Million INR | 91.01% |
| SAMSRITA LABS LIMITED | - INR | -Infinity% |
| Servoteach Industries Limited | 5059.00 INR | -372898.616% |
| SMS Lifesciences India Limited | 331.45 Million INR | 94.307% |
| Supriya Lifescience Limited | 50.2 Million INR | 62.41% |
| Syngene International Limited | 1 Billion INR | 98.113% |
| TAKE Solutions Limited | 7.5 Million INR | -151.6% |
| Titan Biotech Limited | 4.53 Million INR | -316.281% |
| Transgene Biotek Limited | 50.79 Million INR | 62.851% |
| Vanta Bioscience Limited | 488.01 Million INR | 96.133% |